UBS Lowers Numbers on CME Group (CME) Post Q3, Maintains Buy on Upside Opportunity

October 26, 2012 12:43 PM

UBS trimmed estimates and its price target on CME Group (NASDAQ: CME) from $66 to $64 but kept its Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found